Switching from Tenofovir Disoproxil to Tenofovir Alafenamide Fumarate: Impact on Cardiovascular Risk and Lipid Profile in People Living with HIV, an Observational Study-Reference-Cited by-同舟云学术

Switching from Tenofovir Disoproxil to Tenofovir Alafenamide Fumarate: Impact on Cardiovascular Risk and Lipid Profile in People Living with HIV, an Observational Study

Published:2023-02-01 Issue:2 Volume:39 Page:68-75
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Moschopoulos Charalampos D.¹^ORCID,Protopapas Konstantinos¹,Thomas Konstantinos¹,Kavatha Dimitra¹,Papadopoulos Antonios¹,Antoniadou Anastasia¹

Affiliation:

1. Fourth Department of Internal Medicine, National and Kapodistrian University of Athens School of Medicine, Attikon University Hospital, Athens, Greece.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2022.0086

Reference32 articles.

1. HIV and cardiovascular disease

2. HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database

3. All-cause mortality in treated HIV-infected adults with CD4 >=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

4. Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer

5. Management of Reduced Bone Mineral Density in HIV: Pharmacological Challenges and the Role of Exercise

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas;Life;2024-03-28

2. Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives;Hellenic Journal of Cardiology;2023-05

3. Long-Term Evaluation of Changes in Kidney Function after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients Living with HIV;Pharmacy;2022-11-30